Notice of Interim Results

RNS Number : 1001B
Advanced Medical Solutions Grp PLC
12 August 2008
 



For immediate release 

12 August 2008



Advanced Medical Solutions Group plc

('AMS' or 'the Company')


Notice of Interim Results


Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global woundcare technology 
company, will announce its 
interim results for the six months ended 30 June 2008 on Tuesday 9 September 
2008 


An analyst briefing will be held at 9.30am at Buchanan Communications, 45 Moorfields, London EC2, on the 
day of the announcement. 





For further information, please contact:


Advanced Medical Solutions Group plc

+44 (0) 01606 545508

Don Evans, Chief Executive Officer


Mary Tavener, Group Finance Director


www.admedsol.com




Buchanan Communications

+44 (0) 020 7466 5000

Mark Court / Mary-Jane Johnson / Stasa Filiplic




Landsbanki Securities (UK) Ltd

Shaun Dobson, Claes Spang

               +44 (0) 20 7426 9000




Notes to Editors


Advanced Medical Solutions is a leading company in the development, manufacture and sale of products into the $15 billion global woundcare market.


Founded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on the design, development and manufacture of innovative products for advanced woundcare and wound closure.


In-house natural and synthetic polymer technology is used to provide advanced wound dressings based on the moist healing principle. AMS' resources ensure a unique position as a vertically integrated 'one stop shop' to provide all categories of moist wound healing products. The Company has the capability to move a product from design and development through to production and delivery ready for distribution into customer markets.


AMS' technology in cyanoacrylate based tissue adhesives is used either for the closure of small cuts and trauma wounds through to large surgical incisions, or for protecting or sealing skin to prevent breakdown or infection. 


AMS' products currently serve the majority of the key global markets sold either direct or through strategic partners or distributors.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NOREFLFFVVBXBBX
UK 100

Latest directors dealings